Table of Content

1 Study Coverage
1.1 Tuberculosis Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Tuberculosis Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 First Line Drugs Therapy
1.2.3 Second Line Drugs Therapy
1.2.4 Combination Drugs Therapy
1.3 Market by Application
1.3.1 Global Tuberculosis Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Private Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Tuberculosis Drugs Sales Estimates and Forecasts 2018-2029
2.2 Global Tuberculosis Drugs Revenue by Region
2.2.1 Global Tuberculosis Drugs Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Tuberculosis Drugs Revenue by Region (2018-2024)
2.2.3 Global Tuberculosis Drugs Revenue by Region (2024-2029)
2.2.4 Global Tuberculosis Drugs Revenue Market Share by Region (2018-2029)
2.3 Global Tuberculosis Drugs Sales Estimates and Forecasts 2018-2029
2.4 Global Tuberculosis Drugs Sales by Region
2.4.1 Global Tuberculosis Drugs Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Tuberculosis Drugs Sales by Region (2018-2024)
2.4.3 Global Tuberculosis Drugs Sales by Region (2024-2029)
2.4.4 Global Tuberculosis Drugs Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Tuberculosis Drugs Sales by Manufacturers
3.1.1 Global Tuberculosis Drugs Sales by Manufacturers (2018-2024)
3.1.2 Global Tuberculosis Drugs Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Tuberculosis Drugs in 2022
3.2 Global Tuberculosis Drugs Revenue by Manufacturers
3.2.1 Global Tuberculosis Drugs Revenue by Manufacturers (2018-2024)
3.2.2 Global Tuberculosis Drugs Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Tuberculosis Drugs Revenue in 2022
3.3 Global Key Players of Tuberculosis Drugs, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Tuberculosis Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Tuberculosis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Tuberculosis Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Tuberculosis Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Tuberculosis Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Tuberculosis Drugs Sales by Type
4.1.1 Global Tuberculosis Drugs Historical Sales by Type (2018-2024)
4.1.2 Global Tuberculosis Drugs Forecasted Sales by Type (2024-2029)
4.1.3 Global Tuberculosis Drugs Sales Market Share by Type (2018-2029)
4.2 Global Tuberculosis Drugs Revenue by Type
4.2.1 Global Tuberculosis Drugs Historical Revenue by Type (2018-2024)
4.2.2 Global Tuberculosis Drugs Forecasted Revenue by Type (2024-2029)
4.2.3 Global Tuberculosis Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Tuberculosis Drugs Price by Type
4.3.1 Global Tuberculosis Drugs Price by Type (2018-2024)
4.3.2 Global Tuberculosis Drugs Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Tuberculosis Drugs Sales by Application
5.1.1 Global Tuberculosis Drugs Historical Sales by Application (2018-2024)
5.1.2 Global Tuberculosis Drugs Forecasted Sales by Application (2024-2029)
5.1.3 Global Tuberculosis Drugs Sales Market Share by Application (2018-2029)
5.2 Global Tuberculosis Drugs Revenue by Application
5.2.1 Global Tuberculosis Drugs Historical Revenue by Application (2018-2024)
5.2.2 Global Tuberculosis Drugs Forecasted Revenue by Application (2024-2029)
5.2.3 Global Tuberculosis Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Tuberculosis Drugs Price by Application
5.3.1 Global Tuberculosis Drugs Price by Application (2018-2024)
5.3.2 Global Tuberculosis Drugs Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Tuberculosis Drugs Market Size by Type
6.1.1 US & Canada Tuberculosis Drugs Sales by Type (2018-2029)
6.1.2 US & Canada Tuberculosis Drugs Revenue by Type (2018-2029)
6.2 US & Canada Tuberculosis Drugs Market Size by Application
6.2.1 US & Canada Tuberculosis Drugs Sales by Application (2018-2029)
6.2.2 US & Canada Tuberculosis Drugs Revenue by Application (2018-2029)
6.3 US & Canada Tuberculosis Drugs Market Size by Country
6.3.1 US & Canada Tuberculosis Drugs Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Tuberculosis Drugs Sales by Country (2018-2029)
6.3.3 US & Canada Tuberculosis Drugs Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Tuberculosis Drugs Market Size by Type
7.1.1 Europe Tuberculosis Drugs Sales by Type (2018-2029)
7.1.2 Europe Tuberculosis Drugs Revenue by Type (2018-2029)
7.2 Europe Tuberculosis Drugs Market Size by Application
7.2.1 Europe Tuberculosis Drugs Sales by Application (2018-2029)
7.2.2 Europe Tuberculosis Drugs Revenue by Application (2018-2029)
7.3 Europe Tuberculosis Drugs Market Size by Country
7.3.1 Europe Tuberculosis Drugs Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Tuberculosis Drugs Sales by Country (2018-2029)
7.3.3 Europe Tuberculosis Drugs Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Tuberculosis Drugs Market Size
8.1.1 China Tuberculosis Drugs Sales (2018-2029)
8.1.2 China Tuberculosis Drugs Revenue (2018-2029)
8.2 China Tuberculosis Drugs Market Size by Application
8.2.1 China Tuberculosis Drugs Sales by Application (2018-2029)
8.2.2 China Tuberculosis Drugs Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Tuberculosis Drugs Market Size by Type
9.1.1 Asia Tuberculosis Drugs Sales by Type (2018-2029)
9.1.2 Asia Tuberculosis Drugs Revenue by Type (2018-2029)
9.2 Asia Tuberculosis Drugs Market Size by Application
9.2.1 Asia Tuberculosis Drugs Sales by Application (2018-2029)
9.2.2 Asia Tuberculosis Drugs Revenue by Application (2018-2029)
9.3 Asia Tuberculosis Drugs Sales by Region
9.3.1 Asia Tuberculosis Drugs Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Tuberculosis Drugs Revenue by Region (2018-2029)
9.3.3 Asia Tuberculosis Drugs Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Tuberculosis Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America Tuberculosis Drugs Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Tuberculosis Drugs Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Tuberculosis Drugs Market Size by Application
10.2.1 Middle East, Africa and Latin America Tuberculosis Drugs Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Tuberculosis Drugs Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Tuberculosis Drugs Sales by Country
10.3.1 Middle East, Africa and Latin America Tuberculosis Drugs Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Tuberculosis Drugs Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Tuberculosis Drugs Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Pfizer Inc
11.1.1 Pfizer Inc Company Information
11.1.2 Pfizer Inc Overview
11.1.3 Pfizer Inc Tuberculosis Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Pfizer Inc Tuberculosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Inc Recent Developments
11.2 Lupin Laboratories Ltd
11.2.1 Lupin Laboratories Ltd Company Information
11.2.2 Lupin Laboratories Ltd Overview
11.2.3 Lupin Laboratories Ltd Tuberculosis Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Lupin Laboratories Ltd Tuberculosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Lupin Laboratories Ltd Recent Developments
11.3 AstraZeneca Plc
11.3.1 AstraZeneca Plc Company Information
11.3.2 AstraZeneca Plc Overview
11.3.3 AstraZeneca Plc Tuberculosis Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 AstraZeneca Plc Tuberculosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 AstraZeneca Plc Recent Developments
11.4 Cadila Pharmaceuticals
11.4.1 Cadila Pharmaceuticals Company Information
11.4.2 Cadila Pharmaceuticals Overview
11.4.3 Cadila Pharmaceuticals Tuberculosis Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Cadila Pharmaceuticals Tuberculosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Cadila Pharmaceuticals Recent Developments
11.5 Novartis AG
11.5.1 Novartis AG Company Information
11.5.2 Novartis AG Overview
11.5.3 Novartis AG Tuberculosis Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Novartis AG Tuberculosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Novartis AG Recent Developments
11.6 Alkem Laboratories Ltd
11.6.1 Alkem Laboratories Ltd Company Information
11.6.2 Alkem Laboratories Ltd Overview
11.6.3 Alkem Laboratories Ltd Tuberculosis Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Alkem Laboratories Ltd Tuberculosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Alkem Laboratories Ltd Recent Developments
11.7 Cipla Ltd
11.7.1 Cipla Ltd Company Information
11.7.2 Cipla Ltd Overview
11.7.3 Cipla Ltd Tuberculosis Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Cipla Ltd Tuberculosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Cipla Ltd Recent Developments
11.8 Otsuka Pharmaceutical
11.8.1 Otsuka Pharmaceutical Company Information
11.8.2 Otsuka Pharmaceutical Overview
11.8.3 Otsuka Pharmaceutical Tuberculosis Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Otsuka Pharmaceutical Tuberculosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Otsuka Pharmaceutical Recent Developments
11.9 Sanofi
11.9.1 Sanofi Company Information
11.9.2 Sanofi Overview
11.9.3 Sanofi Tuberculosis Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Sanofi Tuberculosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Sanofi Recent Developments
11.10 Abbott
11.10.1 Abbott Company Information
11.10.2 Abbott Overview
11.10.3 Abbott Tuberculosis Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Abbott Tuberculosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Abbott Recent Developments
11.11 ANI Pharmaceuticals, Inc
11.11.1 ANI Pharmaceuticals, Inc Company Information
11.11.2 ANI Pharmaceuticals, Inc Overview
11.11.3 ANI Pharmaceuticals, Inc Tuberculosis Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 ANI Pharmaceuticals, Inc Tuberculosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 ANI Pharmaceuticals, Inc Recent Developments
11.12 Teva Pharmaceutical Industries Ltd
11.12.1 Teva Pharmaceutical Industries Ltd Company Information
11.12.2 Teva Pharmaceutical Industries Ltd Overview
11.12.3 Teva Pharmaceutical Industries Ltd Tuberculosis Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Teva Pharmaceutical Industries Ltd Tuberculosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Teva Pharmaceutical Industries Ltd Recent Developments
11.13 Macleods Pharmaceuticals Ltd.
11.13.1 Macleods Pharmaceuticals Ltd. Company Information
11.13.2 Macleods Pharmaceuticals Ltd. Overview
11.13.3 Macleods Pharmaceuticals Ltd. Tuberculosis Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Macleods Pharmaceuticals Ltd. Tuberculosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Macleods Pharmaceuticals Ltd. Recent Developments
11.14 Johnson & Johnson
11.14.1 Johnson & Johnson Company Information
11.14.2 Johnson & Johnson Overview
11.14.3 Johnson & Johnson Tuberculosis Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Johnson & Johnson Tuberculosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Johnson & Johnson Recent Developments
11.15 FRESENIUS SE & Co. KGaA (Fresenius Kabi)
11.15.1 FRESENIUS SE & Co. KGaA (Fresenius Kabi) Company Information
11.15.2 FRESENIUS SE & Co. KGaA (Fresenius Kabi) Overview
11.15.3 FRESENIUS SE & Co. KGaA (Fresenius Kabi) Tuberculosis Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 FRESENIUS SE & Co. KGaA (Fresenius Kabi) Tuberculosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 FRESENIUS SE & Co. KGaA (Fresenius Kabi) Recent Developments
11.16 Eli Lilly and Company
11.16.1 Eli Lilly and Company Company Information
11.16.2 Eli Lilly and Company Overview
11.16.3 Eli Lilly and Company Tuberculosis Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 Eli Lilly and Company Tuberculosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Eli Lilly and Company Recent Developments
11.17 Viatris Inc. (Mylan N.V.)
11.17.1 Viatris Inc. (Mylan N.V.) Company Information
11.17.2 Viatris Inc. (Mylan N.V.) Overview
11.17.3 Viatris Inc. (Mylan N.V.) Tuberculosis Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.17.4 Viatris Inc. (Mylan N.V.) Tuberculosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Viatris Inc. (Mylan N.V.) Recent Developments
11.18 Sun Pharmaceutical Industries Ltd.
11.18.1 Sun Pharmaceutical Industries Ltd. Company Information
11.18.2 Sun Pharmaceutical Industries Ltd. Overview
11.18.3 Sun Pharmaceutical Industries Ltd. Tuberculosis Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.18.4 Sun Pharmaceutical Industries Ltd. Tuberculosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Sun Pharmaceutical Industries Ltd. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Tuberculosis Drugs Industry Chain Analysis
12.2 Tuberculosis Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Tuberculosis Drugs Production Mode & Process
12.4 Tuberculosis Drugs Sales and Marketing
12.4.1 Tuberculosis Drugs Sales Channels
12.4.2 Tuberculosis Drugs Distributors
12.5 Tuberculosis Drugs Customers
13 Market Dynamics
13.1 Tuberculosis Drugs Industry Trends
13.2 Tuberculosis Drugs Market Drivers
13.3 Tuberculosis Drugs Market Challenges
13.4 Tuberculosis Drugs Market Restraints
14 Key Findings in The Global Tuberculosis Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Tuberculosis Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of First Line Drugs Therapy
Table 3. Major Manufacturers of Second Line Drugs Therapy
Table 4. Major Manufacturers of Combination Drugs Therapy
Table 5. Global Tuberculosis Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Tuberculosis Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Tuberculosis Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Tuberculosis Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Tuberculosis Drugs Revenue Market Share by Region (2018-2024)
Table 10. Global Tuberculosis Drugs Revenue Market Share by Region (2024-2029)
Table 11. Global Tuberculosis Drugs Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Tuberculosis Drugs Sales by Region (2018-2024) & (K Units)
Table 13. Global Tuberculosis Drugs Sales by Region (2024-2029) & (K Units)
Table 14. Global Tuberculosis Drugs Sales Market Share by Region (2018-2024)
Table 15. Global Tuberculosis Drugs Sales Market Share by Region (2024-2029)
Table 16. Global Tuberculosis Drugs Sales by Manufacturers (2018-2024) & (K Units)
Table 17. Global Tuberculosis Drugs Sales Share by Manufacturers (2018-2024)
Table 18. Global Tuberculosis Drugs Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Tuberculosis Drugs Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of Tuberculosis Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. Tuberculosis Drugs Price by Manufacturers 2018-2024 (USD/Unit)
Table 22. Global Tuberculosis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Tuberculosis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Drugs as of 2022)
Table 24. Global Key Manufacturers of Tuberculosis Drugs, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Tuberculosis Drugs, Product Offered and Application
Table 26. Global Key Manufacturers of Tuberculosis Drugs, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Tuberculosis Drugs Sales by Type (2018-2024) & (K Units)
Table 29. Global Tuberculosis Drugs Sales by Type (2024-2029) & (K Units)
Table 30. Global Tuberculosis Drugs Sales Share by Type (2018-2024)
Table 31. Global Tuberculosis Drugs Sales Share by Type (2024-2029)
Table 32. Global Tuberculosis Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Tuberculosis Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Tuberculosis Drugs Revenue Share by Type (2018-2024)
Table 35. Global Tuberculosis Drugs Revenue Share by Type (2024-2029)
Table 36. Tuberculosis Drugs Price by Type (2018-2024) & (USD/Unit)
Table 37. Global Tuberculosis Drugs Price Forecast by Type (2024-2029) & (USD/Unit)
Table 38. Global Tuberculosis Drugs Sales by Application (2018-2024) & (K Units)
Table 39. Global Tuberculosis Drugs Sales by Application (2024-2029) & (K Units)
Table 40. Global Tuberculosis Drugs Sales Share by Application (2018-2024)
Table 41. Global Tuberculosis Drugs Sales Share by Application (2024-2029)
Table 42. Global Tuberculosis Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Tuberculosis Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Tuberculosis Drugs Revenue Share by Application (2018-2024)
Table 45. Global Tuberculosis Drugs Revenue Share by Application (2024-2029)
Table 46. Tuberculosis Drugs Price by Application (2018-2024) & (USD/Unit)
Table 47. Global Tuberculosis Drugs Price Forecast by Application (2024-2029) & (USD/Unit)
Table 48. US & Canada Tuberculosis Drugs Sales by Type (2018-2024) & (K Units)
Table 49. US & Canada Tuberculosis Drugs Sales by Type (2024-2029) & (K Units)
Table 50. US & Canada Tuberculosis Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada Tuberculosis Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Tuberculosis Drugs Sales by Application (2018-2024) & (K Units)
Table 53. US & Canada Tuberculosis Drugs Sales by Application (2024-2029) & (K Units)
Table 54. US & Canada Tuberculosis Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada Tuberculosis Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Tuberculosis Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Tuberculosis Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada Tuberculosis Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Tuberculosis Drugs Sales by Country (2018-2024) & (K Units)
Table 60. US & Canada Tuberculosis Drugs Sales by Country (2024-2029) & (K Units)
Table 61. Europe Tuberculosis Drugs Sales by Type (2018-2024) & (K Units)
Table 62. Europe Tuberculosis Drugs Sales by Type (2024-2029) & (K Units)
Table 63. Europe Tuberculosis Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe Tuberculosis Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Tuberculosis Drugs Sales by Application (2018-2024) & (K Units)
Table 66. Europe Tuberculosis Drugs Sales by Application (2024-2029) & (K Units)
Table 67. Europe Tuberculosis Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe Tuberculosis Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Tuberculosis Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Tuberculosis Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe Tuberculosis Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Tuberculosis Drugs Sales by Country (2018-2024) & (K Units)
Table 73. Europe Tuberculosis Drugs Sales by Country (2024-2029) & (K Units)
Table 74. China Tuberculosis Drugs Sales by Type (2018-2024) & (K Units)
Table 75. China Tuberculosis Drugs Sales by Type (2024-2029) & (K Units)
Table 76. China Tuberculosis Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 77. China Tuberculosis Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Tuberculosis Drugs Sales by Application (2018-2024) & (K Units)
Table 79. China Tuberculosis Drugs Sales by Application (2024-2029) & (K Units)
Table 80. China Tuberculosis Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 81. China Tuberculosis Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Tuberculosis Drugs Sales by Type (2018-2024) & (K Units)
Table 83. Asia Tuberculosis Drugs Sales by Type (2024-2029) & (K Units)
Table 84. Asia Tuberculosis Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia Tuberculosis Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Tuberculosis Drugs Sales by Application (2018-2024) & (K Units)
Table 87. Asia Tuberculosis Drugs Sales by Application (2024-2029) & (K Units)
Table 88. Asia Tuberculosis Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia Tuberculosis Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Tuberculosis Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Tuberculosis Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia Tuberculosis Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Tuberculosis Drugs Sales by Region (2018-2024) & (K Units)
Table 94. Asia Tuberculosis Drugs Sales by Region (2024-2029) & (K Units)
Table 95. Middle East, Africa and Latin America Tuberculosis Drugs Sales by Type (2018-2024) & (K Units)
Table 96. Middle East, Africa and Latin America Tuberculosis Drugs Sales by Type (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Tuberculosis Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Tuberculosis Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Tuberculosis Drugs Sales by Application (2018-2024) & (K Units)
Table 100. Middle East, Africa and Latin America Tuberculosis Drugs Sales by Application (2024-2029) & (K Units)
Table 101. Middle East, Africa and Latin America Tuberculosis Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Tuberculosis Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Tuberculosis Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Tuberculosis Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Tuberculosis Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Tuberculosis Drugs Sales by Country (2018-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Tuberculosis Drugs Sales by Country (2024-2029) & (K Units)
Table 108. Pfizer Inc Company Information
Table 109. Pfizer Inc Description and Major Businesses
Table 110. Pfizer Inc Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 111. Pfizer Inc Tuberculosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Pfizer Inc Recent Developments
Table 113. Lupin Laboratories Ltd Company Information
Table 114. Lupin Laboratories Ltd Description and Major Businesses
Table 115. Lupin Laboratories Ltd Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 116. Lupin Laboratories Ltd Tuberculosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Lupin Laboratories Ltd Recent Developments
Table 118. AstraZeneca Plc Company Information
Table 119. AstraZeneca Plc Description and Major Businesses
Table 120. AstraZeneca Plc Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 121. AstraZeneca Plc Tuberculosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. AstraZeneca Plc Recent Developments
Table 123. Cadila Pharmaceuticals Company Information
Table 124. Cadila Pharmaceuticals Description and Major Businesses
Table 125. Cadila Pharmaceuticals Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 126. Cadila Pharmaceuticals Tuberculosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Cadila Pharmaceuticals Recent Developments
Table 128. Novartis AG Company Information
Table 129. Novartis AG Description and Major Businesses
Table 130. Novartis AG Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 131. Novartis AG Tuberculosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Novartis AG Recent Developments
Table 133. Alkem Laboratories Ltd Company Information
Table 134. Alkem Laboratories Ltd Description and Major Businesses
Table 135. Alkem Laboratories Ltd Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 136. Alkem Laboratories Ltd Tuberculosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Alkem Laboratories Ltd Recent Developments
Table 138. Cipla Ltd Company Information
Table 139. Cipla Ltd Description and Major Businesses
Table 140. Cipla Ltd Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 141. Cipla Ltd Tuberculosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Cipla Ltd Recent Developments
Table 143. Otsuka Pharmaceutical Company Information
Table 144. Otsuka Pharmaceutical Description and Major Businesses
Table 145. Otsuka Pharmaceutical Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 146. Otsuka Pharmaceutical Tuberculosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Otsuka Pharmaceutical Recent Developments
Table 148. Sanofi Company Information
Table 149. Sanofi Description and Major Businesses
Table 150. Sanofi Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 151. Sanofi Tuberculosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Sanofi Recent Developments
Table 153. Abbott Company Information
Table 154. Abbott Description and Major Businesses
Table 155. Abbott Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 156. Abbott Tuberculosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Abbott Recent Developments
Table 158. ANI Pharmaceuticals, Inc Company Information
Table 159. ANI Pharmaceuticals, Inc Description and Major Businesses
Table 160. ANI Pharmaceuticals, Inc Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 161. ANI Pharmaceuticals, Inc Tuberculosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. ANI Pharmaceuticals, Inc Recent Developments
Table 163. Teva Pharmaceutical Industries Ltd Company Information
Table 164. Teva Pharmaceutical Industries Ltd Description and Major Businesses
Table 165. Teva Pharmaceutical Industries Ltd Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 166. Teva Pharmaceutical Industries Ltd Tuberculosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. Teva Pharmaceutical Industries Ltd Recent Developments
Table 168. Macleods Pharmaceuticals Ltd. Company Information
Table 169. Macleods Pharmaceuticals Ltd. Description and Major Businesses
Table 170. Macleods Pharmaceuticals Ltd. Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 171. Macleods Pharmaceuticals Ltd. Tuberculosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. Macleods Pharmaceuticals Ltd. Recent Developments
Table 173. Johnson & Johnson Company Information
Table 174. Johnson & Johnson Description and Major Businesses
Table 175. Johnson & Johnson Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 176. Johnson & Johnson Tuberculosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 177. Johnson & Johnson Recent Developments
Table 178. FRESENIUS SE & Co. KGaA (Fresenius Kabi) Company Information
Table 179. FRESENIUS SE & Co. KGaA (Fresenius Kabi) Description and Major Businesses
Table 180. FRESENIUS SE & Co. KGaA (Fresenius Kabi) Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 181. FRESENIUS SE & Co. KGaA (Fresenius Kabi) Tuberculosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 182. FRESENIUS SE & Co. KGaA (Fresenius Kabi) Recent Developments
Table 183. Eli Lilly and Company Company Information
Table 184. Eli Lilly and Company Description and Major Businesses
Table 185. Eli Lilly and Company Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 186. Eli Lilly and Company Tuberculosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 187. Eli Lilly and Company Recent Developments
Table 188. Viatris Inc. (Mylan N.V.) Company Information
Table 189. Viatris Inc. (Mylan N.V.) Description and Major Businesses
Table 190. Viatris Inc. (Mylan N.V.) Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 191. Viatris Inc. (Mylan N.V.) Tuberculosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 192. Viatris Inc. (Mylan N.V.) Recent Developments
Table 193. Sun Pharmaceutical Industries Ltd. Company Information
Table 194. Sun Pharmaceutical Industries Ltd. Description and Major Businesses
Table 195. Sun Pharmaceutical Industries Ltd. Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 196. Sun Pharmaceutical Industries Ltd. Tuberculosis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 197. Sun Pharmaceutical Industries Ltd. Recent Developments
Table 198. Key Raw Materials Lists
Table 199. Raw Materials Key Suppliers Lists
Table 200. Tuberculosis Drugs Distributors List
Table 201. Tuberculosis Drugs Customers List
Table 202. Tuberculosis Drugs Market Trends
Table 203. Tuberculosis Drugs Market Drivers
Table 204. Tuberculosis Drugs Market Challenges
Table 205. Tuberculosis Drugs Market Restraints
Table 206. Research Programs/Design for This Report
Table 207. Key Data Information from Secondary Sources
Table 208. Key Data Information from Primary Sources
List of Figures
Figure 1. Tuberculosis Drugs Product Picture
Figure 2. Global Tuberculosis Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Tuberculosis Drugs Market Share by Type in 2022 & 2029
Figure 4. First Line Drugs Therapy Product Picture
Figure 5. Second Line Drugs Therapy Product Picture
Figure 6. Combination Drugs Therapy Product Picture
Figure 7. Global Tuberculosis Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Tuberculosis Drugs Market Share by Application in 2022 & 2029
Figure 9. Hospital
Figure 10. Private Clinic
Figure 11. Others
Figure 12. Tuberculosis Drugs Report Years Considered
Figure 13. Global Tuberculosis Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Tuberculosis Drugs Revenue 2018-2029 (US$ Million)
Figure 15. Global Tuberculosis Drugs Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Tuberculosis Drugs Revenue Market Share by Region (2018-2029)
Figure 17. Global Tuberculosis Drugs Sales 2018-2029 ((K Units)
Figure 18. Global Tuberculosis Drugs Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Tuberculosis Drugs Sales YoY (2018-2029) & (K Units)
Figure 20. US & Canada Tuberculosis Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Tuberculosis Drugs Sales YoY (2018-2029) & (K Units)
Figure 22. Europe Tuberculosis Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Tuberculosis Drugs Sales YoY (2018-2029) & (K Units)
Figure 24. China Tuberculosis Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Tuberculosis Drugs Sales YoY (2018-2029) & (K Units)
Figure 26. Asia (excluding China) Tuberculosis Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Tuberculosis Drugs Sales YoY (2018-2029) & (K Units)
Figure 28. Middle East, Africa and Latin America Tuberculosis Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Tuberculosis Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Tuberculosis Drugs in the World: Market Share by Tuberculosis Drugs Revenue in 2022
Figure 31. Global Tuberculosis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Tuberculosis Drugs Sales Market Share by Type (2018-2029)
Figure 33. Global Tuberculosis Drugs Revenue Market Share by Type (2018-2029)
Figure 34. Global Tuberculosis Drugs Sales Market Share by Application (2018-2029)
Figure 35. Global Tuberculosis Drugs Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Tuberculosis Drugs Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Tuberculosis Drugs Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Tuberculosis Drugs Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Tuberculosis Drugs Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Tuberculosis Drugs Revenue Share by Country (2018-2029)
Figure 41. US & Canada Tuberculosis Drugs Sales Share by Country (2018-2029)
Figure 42. U.S. Tuberculosis Drugs Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Tuberculosis Drugs Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Tuberculosis Drugs Sales Market Share by Type (2018-2029)
Figure 45. Europe Tuberculosis Drugs Revenue Market Share by Type (2018-2029)
Figure 46. Europe Tuberculosis Drugs Sales Market Share by Application (2018-2029)
Figure 47. Europe Tuberculosis Drugs Revenue Market Share by Application (2018-2029)
Figure 48. Europe Tuberculosis Drugs Revenue Share by Country (2018-2029)
Figure 49. Europe Tuberculosis Drugs Sales Share by Country (2018-2029)
Figure 50. Germany Tuberculosis Drugs Revenue (2018-2029) & (US$ Million)
Figure 51. France Tuberculosis Drugs Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. Tuberculosis Drugs Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Tuberculosis Drugs Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Tuberculosis Drugs Revenue (2018-2029) & (US$ Million)
Figure 55. China Tuberculosis Drugs Sales Market Share by Type (2018-2029)
Figure 56. China Tuberculosis Drugs Revenue Market Share by Type (2018-2029)
Figure 57. China Tuberculosis Drugs Sales Market Share by Application (2018-2029)
Figure 58. China Tuberculosis Drugs Revenue Market Share by Application (2018-2029)
Figure 59. Asia Tuberculosis Drugs Sales Market Share by Type (2018-2029)
Figure 60. Asia Tuberculosis Drugs Revenue Market Share by Type (2018-2029)
Figure 61. Asia Tuberculosis Drugs Sales Market Share by Application (2018-2029)
Figure 62. Asia Tuberculosis Drugs Revenue Market Share by Application (2018-2029)
Figure 63. Asia Tuberculosis Drugs Revenue Share by Region (2018-2029)
Figure 64. Asia Tuberculosis Drugs Sales Share by Region (2018-2029)
Figure 65. Japan Tuberculosis Drugs Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Tuberculosis Drugs Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Tuberculosis Drugs Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Tuberculosis Drugs Revenue (2018-2029) & (US$ Million)
Figure 69. India Tuberculosis Drugs Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Tuberculosis Drugs Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Tuberculosis Drugs Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Tuberculosis Drugs Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Tuberculosis Drugs Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Tuberculosis Drugs Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Tuberculosis Drugs Sales Share by Country (2018-2029)
Figure 76. Brazil Tuberculosis Drugs Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Tuberculosis Drugs Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Tuberculosis Drugs Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Tuberculosis Drugs Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Tuberculosis Drugs Revenue (2018-2029) & (US$ Million)
Figure 81. Tuberculosis Drugs Value Chain
Figure 82. Tuberculosis Drugs Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed